[{"Assets_0_Q2_USD":353130000.0,"CommonStockSharesOutstanding_0_Q2_shares":47071835.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-47903000.0,"NetIncomeLoss_1_Q2_USD":-38380000.0,"NetIncomeLoss_2_Q2_USD":-66680000.0,"StockholdersEquity_0_Q2_USD":265154000.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]